Treeline Biosciences IPO

treeline.bio

Treeline Biosciences is a developer of a drug discovery platform for precision medicines for cancer and other serious diseases.

Founded2021
Total Funding to Date$472.94MM
Register for Details

For more details on financing and valuation for Treeline Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Treeline Biosciences Ticker Symbol

Treeline Biosciences does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Treeline Biosciences Stock Price

The stock price for Treeline Biosciences will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Treeline Biosciences Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
9/26/2022 Series A-1 $261.27MM raised $XXX.XX $XXX.XX
4/9/2021 Series A $211.67MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Treeline Biosciences in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector